MedPath

Effects of oxidative components on postprandial hyperglycemia and vascular functio

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000019641
Lead Sponsor
Kao Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who take continuous medical treatment 2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease 3) Subjects with smoking habit 4) Subjects who participate in other clinical trials 5) Subjects who are not eligible due to physician`s judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood samples were collected before ingestion and at 0.5, 1, 2, 3 and 4 hours after ingestion. FMD was measured before ingestion and at 1, 2, 3 and 4 hours after ingestion. Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial periods for 4 hrs. Primary outcomes are blood glucose and vascular endothelial function
Secondary Outcome Measures
NameTimeMethod
Key secondary outcomes are insulin, d-ROMs and urinary 8-OHdG
© Copyright 2025. All Rights Reserved by MedPath